德丽

Deli Biotech is a specialized biotechnology company that develops high-throughput screening and single-cell analysis platforms based on proprietary droplet microfluidics technology. The company's systems enable the rapid screening of millions of individual cells or variants, facilitating the discovery of high-affinity antibodies, optimized enzymes, and high-yield microbial strains. By integrating microfluidic chip design, precision instrumentation, and specialized reagents, Deli Biotech provides end-to-end solutions for biopharmaceutical R&D and synthetic biology. Their technology is designed to accelerate the development of biologics and cell therapies by identifying rare functional candidates with significantly higher efficiency than traditional methods.